Minimal Physiologically Based Pharmacokinetic Model of Intravenously and Orally Administered Delta-9-Tetrahydrocannabinol in Healthy Volunteers

被引：0
|
作者：
William R. Wolowich
Robert Greif
Maren Kleine-Brueggeney
Werner Bernhard
Lorenz Theiler
机构：
[1] Nova Southeastern University,College of Pharmacy
[2] University of Bern,University Department of Anesthesiology and Pain Therapy, Inselspital, Bern University Hospital
[3] Guy’s and St. Thomas NHS Foundation Trust,Department of Anesthesia, Evelina London Children’s Hospital
[4] University of Bern,Institute of Forensic Medicine
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2019年 / 44卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 711
页数：20
相关论文
共 50 条
  • [21] Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans
    Naef, M
    Russmann, S
    Petersen-Felix, S
    Brenneisen, R
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (05) : 1176 - 1184
  • [22] Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients
    Stangier, J
    Su, CAPF
    Roth, W
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2000, 28 (04) : 149 - 167
  • [23] THE EFFECTS OF ORALLY-ADMINISTERED DELTA-9-TETRAHYDROCANNABINOL IN MAN ON MOOD AND PERFORMANCE-MEASURES - A DOSE-REPONSE STUDY
    CHESHER, GB
    BIRD, KD
    JACKSON, DM
    PERRIGNON, A
    STARMER, GA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (04) : 861 - 864
  • [24] DELTA-9-TETRAHYDROCANNABINOL DISCRIMINATION IN RATS AS A MODEL FOR CANNABIS INTOXICATION
    BALSTER, RL
    PRESCOTT, WR
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (01): : 55 - 62
  • [25] EXPERIMENTAL STUDIES WITH DELTA-9-TETRAHYDROCANNABINOL IN VOLUNTEERS - 2 DOUBLE-BLIND TRIALS
    DITTRICH, A
    WOGGONST.B
    PSYCHOPHARMACOLOGIA, 1972, 26 : 127 - &
  • [26] PRENATALLY ADMINISTERED DELTA-9-TETRAHYDROCANNABINOL TEMPORARILY INHIBITS THE DEVELOPING HYPOTHALAMOPITUITARY SYSTEM IN RATS
    WENGER, T
    CROIX, D
    TRAMU, G
    LEONARDELLI, J
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (03) : 599 - 602
  • [27] TOXICITY OF DELTA-9-TETRAHYDROCANNABINOL (THC) ADMINISTERED SUBCUTANEOUSLY FOR 13 DAYS TO FEMALE RABBITS
    BANERJEE, BN
    SOFIA, RD
    ERIKSON, D
    IVINS, NJ
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1976, 1 (05): : 769 - 776
  • [28] The urinary disposition of intravenously administered 11-nor-9-carboxy-delta-9-tetrahydrocannabinol in humans
    Dietz, Lisa
    Glaz-Sandberg, Anna
    Nguyen, Hang
    Skopp, Gisela
    Mikus, Gerd
    Aderjan, Rolf
    THERAPEUTIC DRUG MONITORING, 2007, 29 (03) : 368 - 372
  • [29] The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
    D'Souza, DC
    Perry, E
    MacDougall, L
    Ammerman, Y
    Cooper, T
    Wu, YT
    Braley, G
    Gueorguieva, R
    Krystal, JH
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (08) : 1558 - 1572
  • [30] The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis
    Deepak Cyril D'Souza
    Edward Perry
    Lisa MacDougall
    Yola Ammerman
    Thomas Cooper
    Yu-te Wu
    Gabriel Braley
    Ralitza Gueorguieva
    John Harrison Krystal
    Neuropsychopharmacology, 2004, 29 : 1558 - 1572
12345